Shujaa Khan

Huge congratulations to @shujaaK & our @ClevelandClinic Adult Reconstruction Research (CCARR) team at #AAOS 👏 “Cefazolin for All: Safe Implementation of Updated Antibiotic Guidelines in 12,849 Arthroplasty Patients.” in 12,849 arthroplasty pts: ✅ ↑ First-line antibiotic use ✅ ↓ Hypersensitivity events ✅ No increase in readmissions or mortality Data-driven orthopaedics in action.

🚨Mortality after TKA PJI remains high🚨 In a 39-study meta-analysis (83,353 patients; mean 4.4-year follow-up), overall mortality after PJI was 13.3%. Multidisciplinary care and funding are needed to reduce this burden. #Ortho #PJI @BoneJointPortal boneandjoint-org-uk.ccmain.ohionet.org/Article/10.130…

#AAHKS2025 @AAHKS @CleClinicArthGp Ready to roll 🎸

💉 ANCEF for all. In a practice-changing study of over 12,000 patients, our team at Cleveland Clinic evaluated the impact of a revised antibiotic prophylaxis protocol for total joint arthroplasty — centering on cefazolin (Ancef) use. ✅ The findings reinforce that cefazolin is safe for nearly all patients, with true allergy as the only contraindication. 📉 Significant implications for reducing hypersensitivity reactions, optimizing prophylaxis, and improving outcomes. 🏆 Congratulations to Shujaa Khan, MD, on earning 1st Place at Annual Research Day for this impactful work. This is how we advance care through data-driven decisions. #Orthopaedics #TJA #InfectionPrevention #Cefazolin #MSRC #TeamScience #ClevelandClinic #PatientSafety

Honored to receive the 2025 Cash Memorial Award, recognizing our research in health outcomes and resource utilization. Grateful to @nspiuzzi and our whole @CleClinicArthGp team for their unwavering support. Excited to keep pushing forward!

Musculoskeletal interventions are often perceived as low-risk in the context of other medical treatments. However, our meta-analysis challenges this assumption and demonstrates the unfortunate fact that PJI may lead to mortality rates equivalent to common cancers. #orthotwitter

Highlights the serious impact of this rare complication - we need better prevention and treatment strategies! 🔗 Read: arthroplastyjournal.org/article/S0883-…

Great work from @_MichaelRamos_ and the team on this important meta-analysis in @JArthroplasty ! 👏 📅 Mortality after PJI following THA:  • 1 month: 2.2%  • 1 year: 10.6% ⚠️ Highest with 2-stage revision 📊 Comparable to 5-year mortality for melanoma, breast & prostate cancer

🛫✈️ Navigating Postoperative Air Travel After Joint Replacement 🛩️ Our latest @jbjs study tackles the big question: When is it safe to fly after hip/knee replacement? Key takeaways: • Guidelines vary widely • VTE risk needs to be addressed • We need better, standardized patient counseling

Pain in OA is complex and hard to accurately assess. 🔒Limitations in current methods 🧬Biomarkers show promise 🤖Integrating AI and wearables 📈Future is multimodal and personalized Full article: doi.org/10.1002/jor.26…

Great few days @AAOS1 so far with plenty more to come today! #AAOS2025

#AAOS2025 Thursday schedule! Join us!

Great work by @ShujaaK ! Stop by Poster Session 1 (#P045) to check out ‘Healthcare Utilization and PROMs Do Not Vary by BMI Class in Medial UKA.’ Findings show BMI doesn’t impact reoperation rates or clinical improvements—challenging traditional views on BMI as a contraindication g ft or UKA #AAOS2025

Cannot ask for a better crew! #AAOS2025 @CleClinicArthGp Clinical Research Fellows are here 🦾

📢Published📢 🩺 Medical-related readmissions are more common but they can still expect meaningful improvement in hip pain and function 🦴Ortho readmissions are less frequent but these patients may not perceive meaningful improvement at 1-year Read: journals.lww.com/clinorthop/abs…

Through successfully constructing and validating multiple 90d readmission predictive models, this study highlights the distinct risk profiles for medical and ortho-related readmissions. arthroplastyjournal.org/article/S0883-…

“If I have seen further, it is by standing on the shoulders of giants.” Honored to receive the Kappa Delta Young Investigator Award Grateful for the opportunity to advance hip and knee arthroplasty outcomes through a PROMs-based personalized approach. 🦾🦿 @CleClinicArthGp #Innovation #Orthopedics #Gratitude #ORS2025

CMS mandates PROMs reporting. Challenges: 🛠️ Admin burden 💰 High costs 📊 Data management 👥 Engaging patients Key to success: ✅ Integrate PROMs into EHRs 📚 Education on their value 🤝 Collaborate with community resources @nspiuzzi @HuffmanNickelas @IPasqualiniMD

🚨Published🚨 In patients undergoing contralateral THA >1yr apart: ✅ Clinically relevant improvements were similar after both THAs 🏥 Comparable healthcare utilization following both THAs 👉🏼 Read: pubmed.ncbi.nlm.nih.gov/39660679/